advertisement

WGA Rescources

Sakata R 15

Showing records 1 to 15 | Display all abstracts from Sakata R

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Zhang X
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Sakata R
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Guo PY
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Fujishiro T
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Lin C
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Saito H; Nakamura N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Li F
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Nguyen A; Sakata R
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Shirato S; Miyamoto E
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Higashita R; Okamoto K
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Yamada Y
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Yu M
Ophthalmology 2023; 130: 111-119
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Aihara M; Aung T; Lin S; Leung CK
Ophthalmology 2023; 130: 111-119

Issue 23-3

Change Issue


advertisement

Nidek